Literature DB >> 1665287

New highly potent bradykinin B2 receptor antagonists.

D Regoli1, N E Rhaleb, C Tousignant, N Rouissi, F Nantel, D Jukic, G Drapeau.   

Abstract

pA2 values of new B2 receptor antagonists ranging from 7.51 to 8.86 were measured on the rabbit jugular vein, while lower values were observed in the other preparations (for instance, the hamster urinary bladder). The most potent antagonists were those containing a hydroxyproline (Hyp) in position 3, a D-Arg at the N-terminal and a Leu instead of a Phe in position 8, with or without other chemical changes. D-Arg[Hyp3,D-Phe7,Leu8]-BK was found to be competitive, selective for B2 receptors and specific for kinins since it was without effect against substance P and angiotensin II in the rabbit jugular vein. The essential feature for obtaining B2 receptor antagonists appears to be the replacement or reorientation of Phe8 of bradykinin. The rabbit jugular vein provides a sensitive bioassay in which the potency and specificity of B2 receptor antagonists can be adequately evaluated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1665287     DOI: 10.1007/bf01993260

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  5 in total

1.  THE SPIRALLY CUT TRACHEAL STRIP PREPARATION.

Authors:  J W CONSTANTINE
Journal:  J Pharm Pharmacol       Date:  1965-06       Impact factor: 3.765

2.  Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs.

Authors:  R F FURCHGOTT; S BHADRAKOM
Journal:  J Pharmacol Exp Ther       Date:  1953-06       Impact factor: 4.030

Review 3.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

4.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09

5.  Competitive antagonists of bradykinin.

Authors:  R J Vavrek; J M Stewart
Journal:  Peptides       Date:  1985 Mar-Apr       Impact factor: 3.750

  5 in total
  2 in total

Review 1.  Non-adrenergic, non-cholinergic control of the urinary bladder.

Authors:  C H Hoyle
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

2.  Plasma bradykinin and early diabetic nephropathy lesions in type 1 diabetes mellitus.

Authors:  Kevin M Wheelock; Jian Cai; Helen C Looker; Michael L Merchant; Robert G Nelson; Gudeta D Fufaa; E Jennifer Weil; Harold I Feldman; Ramachandran S Vasan; Paul L Kimmel; Brad H Rovin; Michael Mauer; Jon B Klein
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.